Zhou Bo, Zhang Chen, Dai Sheng, Zhao Jin, Li Huaiyu, Peng Yanbin, Chu Yunfeng, Chen Zhong, Qin Haotian, Zeng Hui
Department of Hand, Foot & Vascular Surgery, Peking University Shenzhen Hospital, Shenzhen, China.
School of Clinical Medicine, Hubei University of Medicine, Shiyan, China.
Front Bioeng Biotechnol. 2025 Sep 11;13:1660821. doi: 10.3389/fbioe.2025.1660821. eCollection 2025.
Chronic diabetic wounds remain a major clinical challenge due to persistent ischemia, oxidative stress, and impaired angiogenesis. Injectable hydrogels capable of adapting to irregular wound beds and delivering bioactive cues offer promising therapeutic potential for enhancing tissue regeneration.
We developed a multifunctional injectable hydrogel by incorporating cinnamaldehyde-loaded ZIF-8 nanoparticles (CA@ZIF-8) into a gallic acid-grafted gelatin (GGA) matrix, followed by transglutaminase-mediated crosslinking. The physicochemical characteristics, drug release behavior, and mechanical performance of the CA@ZIF-8/GGA hydrogel were systematically evaluated. assays using human umbilical vein endothelial cells (HUVECs) were conducted to assess cytocompatibility and angiogenic activity. A full-thickness skin wound model in streptozotocin-induced diabetic rats was employed to evaluate wound healing efficacy and biocompatibility.
The CA@ZIF-8/GGA hydrogel exhibited favorable injectability, enhanced mechanical strength, and sustained release of both cinnamaldehyde and Zn. , the hydrogel significantly promoted HUVEC proliferation, migration, and tube formation, accompanied by upregulated expression of CD31 and VEGF. , CA(0.6)@ZIF-8/GGA-treated wounds demonstrated accelerated closure, enhanced granulation tissue formation, increased neovascularization, and re-epithelialization compared with control groups. No histological abnormalities were observed in major organs, indicating good systemic biocompatibility.
This study presents an injectable CA@ZIF-8/GGA composite hydrogel that effectively promotes angiogenesis and diabetic wound regeneration. The synergistic integration of MOF-based controlled release and polyphenol-enhanced bioactivity highlights its potential as a clinically translatable platform for chronic wound management.
由于持续存在的缺血、氧化应激和血管生成受损,慢性糖尿病伤口仍然是一个重大的临床挑战。能够适应不规则伤口床并传递生物活性信号的可注射水凝胶为促进组织再生提供了有前景的治疗潜力。
我们通过将负载肉桂醛的ZIF-8纳米颗粒(CA@ZIF-8)掺入没食子酸接枝的明胶(GGA)基质中,然后进行转谷氨酰胺酶介导的交联,开发了一种多功能可注射水凝胶。系统评估了CA@ZIF-8/GGA水凝胶的物理化学特性、药物释放行为和机械性能。使用人脐静脉内皮细胞(HUVECs)进行实验以评估细胞相容性和血管生成活性。采用链脲佐菌素诱导的糖尿病大鼠全层皮肤伤口模型来评估伤口愈合效果和生物相容性。
CA@ZIF-8/GGA水凝胶表现出良好的可注射性、增强的机械强度以及肉桂醛和锌的持续释放。此外,该水凝胶显著促进HUVEC增殖、迁移和管形成,同时CD31和VEGF的表达上调。此外,与对照组相比,CA(0.6)@ZIF-8/GGA处理的伤口显示出加速闭合、增强的肉芽组织形成、增加的新血管形成和再上皮化。在主要器官中未观察到组织学异常,表明具有良好的全身生物相容性。
本研究提出了一种可注射的CA@ZIF-8/GGA复合水凝胶,其可有效促进血管生成和糖尿病伤口再生。基于金属有机框架的控释和多酚增强的生物活性的协同整合突出了其作为慢性伤口管理的临床可转化平台的潜力。